Infection and Pathogen Control Technology

Biovation is a leading innovator in advanced infection control solutions. Our proprietary silver-based technologies and manufacturing processes have been development for more than a decade. Biovation formulations are consistently providing unique and needed solutions in the emerging infection-control market. Our areas of expertise in this sector closely complement our focus in biopolymer based non-wovens, fibers, films, coatings and nano-materials.products_2

Our expertise in infection and pathogen control, and indeed integrating specialized chemistries with the PLA, allows us to partner with market solution providers to create and deliver customer specified antimicrobial protection to our markets.  For example, critical colonization and infection of wounds present a dual problem for clinicians. First, there is the possibility of delayed wound healing, and second, colonized and infected wounds are a potential source for cross-infection. For patients, an infected wound can have additional consequences including increased pain and discomfort, a delay in return to normal activities, and the possibility of a life-threatening illness. For healthcare providers, there are increases in treatment costs and nursing time to consider. Our technology and competence provides solutions and options for the market to consider in our collective efforts to further the field of wound care.

The two most important functions of surgical or wound dressings are 1) the ability to absorb and hold fluid and 2) the ability to quickly wick and maintain a critical moisture balance of the wound bed to avoid maceration of newly formed tissue and drying or scabbing of the wound.  The wound dressing should be soft, comfortable and conforming to the wound to ensure optimal performance and maximum patient comfort.  In addition, the dressing should release easily from the wound so that the removal of the dressing does not damage the fragile, newly formed tissue.

To further our goals in providing solutions for the wound care market we have developed a manufacturing methodology that we refer to as gel-cast biopolymer matrix which results in a new wound healing absorbent dressing composed of fibers and materials that have inherently low bioburden. The gel-cast biopolymer dressing has the capability to deliver non-toxic antimicrobial agents for infection control properties, with full bio-compatibility. The dressing is non-adherent to body tissue,  This novel absorbent dressing has other advantages such as: high mechanical wet strength in the wound bed, easy conformability to the wound, and a pliable and flexible structure with no sharp edges that can cause pressure and stress in the wound. Even in the event the dressing is cut to shape, there are no sharp edges or material that can disassociate from the dressing and reside in the wound causing a secondary infection site.

Our Healthcare products extend beyond the boundaries of wound care to include solutions to healthcare acquired infection (HAI) mitigation. Healthcare facilities present repeated opportunities for the transmission of infectious pathogens from patient-to-patient, via direct and indirect routes including contaminated surfaces and equipment. The growing concern of healthcare professionals in regard to antibiotic resistant pathogens is creating an increase in desire for disposable hygienic barriers for commonly used equipment, such as blood pressure cuffs. By leveraging our expertise in pathogen control, we have developed a resolution to an ever growing issue within Healthcare Environments. With the integration of a silver and copper antimicrobial technology within our meltblown non-woven fabric, we have developed a hygienic barrier, the BioArmour ™Blood Pressure Cuff Shield, which is applied directly to the blood pressure cuff. The product is created from a non-woven with integrated silver and copper antimicrobial technology that is effective against the most harmful pathogens such as MRSA, K. pneumoniae, VRE, and C. difficile.  The non-woven is laminated to a PLA film, as a roll good, which acts as bodily fluid barrier preventing fluids from contacting the blood pressure cuff by penetrating through the shield. The roll of composite laminate is then converted to the necessary sizes and equipped with an adhesive backing to allow for sustained adhesion to the blood pressure cuff.

Provided as a roll good, the antimicrobial fabric and laminate composite, used as the base technology for the BioArmour™ Blood Pressure Cuff Shield, can be applicable for various other antimicrobial applications within the Commercial and Institutional markets.